Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Behnes

Showing results (61-70 of 330) with videos related to

Pageof 33
Sort By:
Scandinavian Cardiovascular Journal : SCJ|April 9, 2019
Prognostic impact of recurrences in patients with electrical stormJulian Müller, Michael Behnes, Dominik Ellguth, et al.
Shock (Augusta, Ga.)|June 30, 2012
Alterations of adiponectin in the course of inflammation and severe sepsisMichael Behnes, Martina Brueckmann, Siegfried Lang, et al.
Cardiology Journal|October 21, 2021
Feasibility and outcome of the Rotapro system in treating severely calcified coronary lesions: The Rotapro studyMohamed Ayoub, Peter Tajti, Miroslaw Ferenc, et al.
Journal of Cardiovascular Development and Disease|June 23, 2022
Kidney Failure among Patients with Takotsubo Syndrome or Myocardial Infarction: A Retrospective AnalysisVerena Bill, Ibrahim El-Battrawy, Marvin Kummer, et al.
Journal of Cardiovascular Electrophysiology|July 1, 2010
The P-selectin gene polymorphism Val168Met: a novel risk marker for the occurrence of primary ventricular fibrillation during acute myocardial infarctionElif Elmas, Peter Bugert, Tatjana Popp, et al.
Journal of Critical Care|December 6, 2008
Levels of oxidized low-density lipoproteins are increased in patients with severe sepsisMichael Behnes, Martina Brueckmann, Volker Liebe, et al.
Critical Care (London, England)|September 6, 2014
Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatmentMichael Behnes, Thomas Bertsch, Dominic Lepiorz, et al.
Current Medical Research and Opinion|July 8, 2026
Seasonal variations and prognosis of patients with sepsis, septic shock, and cardiogenic shockOmar Hajji, Tobias Schupp, Jan Forner, et al.
Journal of Cardiovascular Development and Disease|August 25, 2022
Carvedilol versus Metoprolol in Patients with Ventricular TachyarrhythmiasTobias Schupp, Michael Behnes, Mohammad Abumayyaleh, et al.
Medicine|November 10, 2018
Unprotected versus protected high-risk percutaneous coronary intervention with the Impella 2.5 in patients with multivessel disease and severely reduced left ventricular functionTobias Becher, Frederik Eder, Stefan Baumann, et al.
Pageof 33

Showing results (61-70 of 330) with videos related to

Sort By:
Pageof 33
Scandinavian Cardiovascular Journal : SCJ|April 9, 2019
Prognostic impact of recurrences in patients with electrical stormJulian Müller, Michael Behnes, Dominik Ellguth, et al.
Shock (Augusta, Ga.)|June 30, 2012
Alterations of adiponectin in the course of inflammation and severe sepsisMichael Behnes, Martina Brueckmann, Siegfried Lang, et al.
Cardiology Journal|October 21, 2021
Feasibility and outcome of the Rotapro system in treating severely calcified coronary lesions: The Rotapro studyMohamed Ayoub, Peter Tajti, Miroslaw Ferenc, et al.
Journal of Cardiovascular Development and Disease|June 23, 2022
Kidney Failure among Patients with Takotsubo Syndrome or Myocardial Infarction: A Retrospective AnalysisVerena Bill, Ibrahim El-Battrawy, Marvin Kummer, et al.
Journal of Cardiovascular Electrophysiology|July 1, 2010
The P-selectin gene polymorphism Val168Met: a novel risk marker for the occurrence of primary ventricular fibrillation during acute myocardial infarctionElif Elmas, Peter Bugert, Tatjana Popp, et al.
Journal of Critical Care|December 6, 2008
Levels of oxidized low-density lipoproteins are increased in patients with severe sepsisMichael Behnes, Martina Brueckmann, Volker Liebe, et al.
Critical Care (London, England)|September 6, 2014
Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatmentMichael Behnes, Thomas Bertsch, Dominic Lepiorz, et al.
Current Medical Research and Opinion|July 8, 2026
Seasonal variations and prognosis of patients with sepsis, septic shock, and cardiogenic shockOmar Hajji, Tobias Schupp, Jan Forner, et al.
Journal of Cardiovascular Development and Disease|August 25, 2022
Carvedilol versus Metoprolol in Patients with Ventricular TachyarrhythmiasTobias Schupp, Michael Behnes, Mohammad Abumayyaleh, et al.
Medicine|November 10, 2018
Unprotected versus protected high-risk percutaneous coronary intervention with the Impella 2.5 in patients with multivessel disease and severely reduced left ventricular functionTobias Becher, Frederik Eder, Stefan Baumann, et al.
Pageof 33